Primary care-based multifaceted, interdisciplinary medical educational intervention for patients with systolic heart failure: lessons learned from a cluster randomised controlled trial.
BACKGROUND
Chronic (systolic) heart failure (CHF) is a common and disabling condition. Adherence to evidence-based guidelines in primary care has been shown to improve health outcomes. The aim was to explore the impact of a multidisciplinary educational intervention for general practitioners (GPs) (Train the trainer = TTT) on patient and performance outcomes.


METHODS
This paper presents the key findings from the trial and discusses the lessons learned during the implementation of the TTT trial. Primary care practices were randomly assigned to the TTT intervention or to the control group. 37 GPs (18 TTT, 19 control) were randomised and 168 patients diagnosed with ascertained CHF (91 TTT, 77 control) were enrolled. GPs in the intervention group attended four meetings addressing clinical practice guidelines and pharmacotherapy feedback. The primary outcome was patient self-reported quality of life at seven months, using the SF-36 Physical Functioning scale. Secondary outcomes included other SF-36 scales, the Kansas City Cardiomyopathy Questionnaire (KCCQ), total mortality, heart failure hospital admissions, prescribing, depressive disorders (PHQ-9), behavioural change (European Heart Failure Self-Care Behaviour Scale), patient-perceived quality of care (EUROPEP) and improvement of heart failure using NT-proBNP-levels. Because recruitment targets were not achieved an exploratory analysis was conducted.


RESULTS
There was high baseline achievement in both groups for many outcomes. At seven months, there were no significant mean difference between groups for the primary outcome measure (-3.3, 95%CI -9.7 to 3.1, p = 0.30). The only difference in secondary outcomes related to the prescribing of aldosterone antagonists by GPs in the intervention group, with significant between group differences at follow-up (42 vs. 24%, adjusted OR = 4.0, 95%CI 1.2-13; p = 0.02).


CONCLUSIONS
The intervention did not change the primary outcome or most secondary outcomes. Recruitment targets were not achieved and the under-recruitment of practices and patients alongside a selection bias of participating GPs, prohibit definite conclusions, but the CI indicates a non-effectiveness of the intervention in this sample. We describe the lessons learned from conducting the trial for the future planning and conduct of confirmatory trials in primary care.


BACKGROUND
ISRCTN08601529.
Peters-Klimm
Frank
F
Department of General Practice and Health Services Research, University Hospital Heidelberg, Heidelberg, Germany. frank.peters@med.uni-heidelberg.de
Campbell
Stephen
S
Müller-Tasch
Thomas
T
Schellberg
Dieter
D
Gelbrich
Goetz
G
Herzog
Wolfgang
W
Szecsenyi
Joachim
J
D000328:Adult; D004502:Education, Medical, Continuing; D005500:Follow-Up Studies; D054143:Heart Failure, Systolic / Q000401:mortality / Q000628:therapy*; D006801:Humans; D020097:Natriuretic Peptide, Brain / Q000097:blood; D010446:Peptide Fragments / Q000097:blood; D010821:Physicians, Family; D011320:Primary Health Care
D010446:Peptide Fragments; C109794:pro-brain natriuretic peptide (1-76); D020097:Natriuretic Peptide, Brain
BMJ. 2003 Jan 25;326(7382):196
12543836
Heart. 2000 Jun;83(6):645-50
10814621
CMAJ. 2009 Mar 3;180(5):520-7
19255076
Eur Heart J. 2005 Jun;26(11):1115-40
15901669
JAMA. 2004 Mar 17;291(11):1358-67
15026403
Eur J Heart Fail. 2003 Jun;5(3):363-70
12798836
J Am Coll Cardiol. 2003 May 7;41(9):1529-38
12742294
Eur Heart J. 2002 Dec;23(23):1867-76
12445536
J Affect Disord. 2004 Feb;78(2):131-40
14706723
Am Heart J. 2006 May;151(5):992-8
16644320
J Eval Clin Pract. 2008 Oct;14(5):823-9
19018915
Qual Life Res. 2005 Mar;14(2):285-95
15892420
J Am Coll Cardiol. 2000 Apr;35(5):1245-55
10758967
BMJ. 2007 May 26;334(7603):1098
17452390
J Eval Clin Pract. 2006 Jun;12(3):334-40
16722919
J Eval Clin Pract. 2003 Aug;9(3):373-82
12895159
Heart. 2007 Jul;93(7):819-25
17065182
Clin Res Cardiol. 2008 Apr;97(4):244-52
18046524
BMJ. 2000 Jan 22;320(7229):224-30
10642233
Eur Heart J. 2002 Jan;23(2):139-46
11785996
Heart. 2000 May;83(5):596-602
10768918
J Eval Clin Pract. 2006 Dec;12(6):613-21
17100860
BMJ. 2000 Sep 9;321(7261):605-7
10977838
Heart. 2002 Mar;87(3):235-41
11847161
Int J Technol Assess Health Care. 2005 Summer;21(3):380-5
16110718
Eur Heart J. 2005 Aug;26(16):1653-9
15827061
Z Kardiol. 2005 Aug;94(8):542-4
16049657
BMJ. 2007 May 5;334(7600):942
17426062
BMC Fam Pract. 2006 Jul 05;7:40
16822303
Eur J Heart Fail. 2005 Aug;7(5):910-20
16087143
Z Kardiol. 2005 Apr;94(4):247-54
15803261
Med Care. 1992 Jun;30(6):473-83
1593914
Br J Gen Pract. 2000 Nov;50(460):882-7
11141874
Cochrane Database Syst Rev. 2001;(2):CD003030
11406063
Br J Gen Pract. 1998 Feb;48(427):991-7
9624774
Lancet. 2005 May 28-Jun 3;365(9474):1877-89
15924986
Am Heart J. 2005 Oct;150(4):707-15
16209970
Br Med J. 1964 Jul 18;2(5402):177
14150898
Eur J Heart Fail. 2008 Oct;10(10):933-89
18826876
Med Educ. 2005 Jun;39(6):557-60
15910430
Health Technol Assess. 2004 Feb;8(6):iii-iv, 1-72
14960256
BMJ. 2007 Jan 20;334(7585):127-9
17235093
Circulation. 2003 Jun 10;107(22):2799-804
12756157
BMJ. 2000 Sep 16;321(7262):694-6
10987780
Am J Cardiol. 1996 Oct 15;78(8):890-5
8888661
J Gen Intern Med. 2001 Sep;16(9):606-13
11556941
Lancet. 2002 Nov 23;360(9346):1631-9
12457785
N Engl J Med. 1996 May 30;334(22):1441-7
8618584
Clin Trials. 2005;2(2):99-107
16279131
N Engl J Med. 2005 Aug 4;353(5):487-97
16079372
J Am Coll Cardiol. 2001 Jun 1;37(7):1781-7
11401111
Fam Pract. 1995 Sep;12(3):313-7
8536837
Z Arztl Fortbild Qualitatssich. 2003 Apr;97(2):98-103
12806814
Fam Pract. 2000 Apr;17(2):192-6
10758085